Making way
for breakthroughs , advancements , discoveries , innovations , evolutions
for breakthroughs , advancements , discoveries , innovations , evolutions
Making way for
breakthroughs , advancements , discoveries , innovations , evolutions
breakthroughs , advancements , discoveries , innovations , evolutions
At Xcellon, we transform scientific breakthroughs into life-saving therapies. As a trusted CDMO, we specialize in complex biologics development and manufacturing, ensuring precision, speed, and scalability from molecule to market.
At Xcellon, we transform scientific advancements into life-saving therapies. As a US-based global CDMO, we specialize in Biopharmaceutical Engineering & Manufacturing, ensuring precision, speed, and scalability from molecule to market.

- Our Offerings
Pioneering Innovation in Biologics Development
We partner with biopharmaceutical leaders to solve the most complex biologics challenges. Our expertise spans:
- Antibody Drug Conjugates (ADCs) & Bioconjugates
- Bispecific Antibodies & T-Cell Engagers
- Bioprocess, Analytical & Formulation Development
- Machine Learning for Process Optimization
- GMP Manufacturing (To be online in 2026)
With decades of expertise and state-of-the-art facilities, we drive therapies with unmatched efficiency and scientific rigor.
- Proven Experience
Decades of Scientific Leadership
Years in Bioconjugation
0
+
Years in Biologics Development
0
+
Years in GMP Manufacturing
0
+
INDs Filed
0
+
Products Launched
0
Backed by industry pioneers with deep expertise in biologics, bio-conjugation, and GMP manufacturing, we deliver excellence at every stage. Strategically located in Maryland, near key US Federal healthcare agencies like the FDA, NIH, and USP, Xcellon is shaping the next era of biopharmaceutical innovation.

- Careers
Shape the Future of Biopharma
Join a fast-growing team at the forefront of scientific discovery.
At Xcellon, every role contributes to something bigger: accelerating life-saving therapies. We are looking for curious, driven innovators ready to push the boundaries of complex biologics development.